Literature DB >> 15222832

Apolipoprotein e gene variability and cognitive functions at age 79: a follow-up of the Scottish mental survey of 1932.

Ian J Deary1, Martha C Whiteman, Alison Pattie, John M Starr, Caroline Hayward, Alan F Wright, Peter M Visscher, Maria C Tynan, Lawrence J Whalley.   

Abstract

Apolipoprotein E (APOE) genotype is a possible influence on nonpathological cognitive aging. The authors studied 462 community-dwelling, 79-year-old people born in 1921, whose childhood IQ had been assessed in the Scottish Mental Survey of 1932 (Scottish Council for Research in Education, 1933). Adjusting for sex, childhood IQ, and self-reported illnesses, the authors found that those with an APOE e4 allele had significantly lower Wechsler Logical Memory (D. Wechsler, 1987) scores than those without an e4 allele. Those people with APOE s2/e3 genotypes had significantly higher Wechsler Logical Memory scores than e3/s3, who were significantly higher than e3/e4. Neither nonverbal reasoning nor verbal fluency were affected. In this sample, APOE genotype contributed to verbal memory in old age. ((c) 2004 APA, all rights reserved)

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222832     DOI: 10.1037/0882-7974.19.2.367

Source DB:  PubMed          Journal:  Psychol Aging        ISSN: 0882-7974


  25 in total

Review 1.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

2.  Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study.

Authors:  Po H Lu; Paul M Thompson; Alex Leow; Grace J Lee; Agatha Lee; Igor Yanovsky; Neelroop Parikshak; Theresa Khoo; Stephanie Wu; Daniel Geschwind; George Bartzokis
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.

Authors:  Naftali Raz; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

Review 4.  Neurobiology of cognitive aging: insights from imaging genetics.

Authors:  Venkata S Mattay; Terry E Goldberg; Fabio Sambataro; Daniel R Weinberger
Journal:  Biol Psychol       Date:  2008-04-11       Impact factor: 3.251

5.  ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriers.

Authors:  G Peggy McFall; Sandra A Wiebe; David Vergote; David Westaway; Jack Jhamandas; Lars Bäckman; Roger A Dixon
Journal:  Neuropsychology       Date:  2014-12-01       Impact factor: 3.295

6.  Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.

Authors:  Danielle C Whitehair; Abdullah Sherzai; Jennifer Emond; Rema Raman; Paul S Aisen; Ronald C Petersen; Adam S Fleisher
Journal:  Alzheimers Dement       Date:  2010-09       Impact factor: 21.566

7.  Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study.

Authors:  D J Lehmann; H Refsum; E Nurk; D R Warden; G S Tell; S E Vollset; K Engedal; H A Nygaard; A D Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-04       Impact factor: 10.154

Review 8.  Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence.

Authors:  F W Sabb; A C Burggren; R G Higier; J Fox; J He; D S Parker; R A Poldrack; W Chu; T D Cannon; N B Freimer; R M Bilder
Journal:  Neuroscience       Date:  2009-05-18       Impact factor: 3.590

9.  APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms.

Authors:  C Conejero-Goldberg; J J Gomar; T Bobes-Bascaran; T M Hyde; J E Kleinman; M M Herman; S Chen; P Davies; T E Goldberg
Journal:  Mol Psychiatry       Date:  2014-02-04       Impact factor: 15.992

10.  Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adults.

Authors:  G Peggy McFall; Shraddha Sapkota; Kirstie L McDermott; Roger A Dixon
Journal:  Neurobiol Aging       Date:  2016-03-10       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.